Clinical studies recruiting near Zhengzhou

Studies with at least one listed site matching this location on the public registry. Each page explains the study in plain language, with locations and study-team contacts. Clinicians: generate a printable list for your patient →

Fruquintinib in Combination With Sintilimab and CAPEOX as First-line Treatment for G/GEJ Cancer
Phase 1/Phase 2 · Henan Cancer Hospital · Henan Cancer Hospital · NCT06329973 A Study to Evaluate Safety, Tolerability and Efficacy of AP306 at Fixed Doses in Dialysis Participants With Hyperphospha
Phase 2 · R1 Therapeutics Clinical Trial Site · R1 Therapeutics · NCT06712654 Carbon Nanoparticle-Loaded Iron in the Treatment of Advanced Solid Tumor
Phase 1/Phase 2 · Sichuan Enray Pharmaceutical Sciences Company · NCT07433283 This Study is a FIH Study Which is Required to Understand the PK Characteristics, MTD, RP2D and Safety Profile.
Phase 1 · Henan Cancer Hospital · Nanjing RegeneCore Biotech Co., Ltd. · NCT06756451 Fruquintinib Combined With Trastuzumab and XELOX as First-line Treatment in Patients With HER2-positive Advanced Gastric
Phase 1/Phase 2 · Henan Cancer Hospital (Affiliated Cancer Hospital of Zhengzh · Henan Cancer Hospital · NCT07334431 Phase II Study of Serplulimab Combined with First-Line Targeted Therapy, Chemotherapy, and Radiation in Advanced Colorec
Phase 2 · The First Affiliated Hospital of Zhengzhou University · Fudan University · NCT06521866 A Study of Nemtabrutinib (MK-1026) Versus Comparator (Investigator's Choice of Ibrutinib or Acalabrutinib) in First Line
Phase 3 · Henan Cancer Hospital-hematology department ( Site 2025) · Merck Sharp & Dohme LLC · NCT06136559 Phase 2/3 Trial of Izalontamab Brengitecan vs Platinum-based Chemotherapy for Metastatic Urothelial Cancer With Disease
Phase 2/Phase 3 · Local Institution - 0064 · Bristol-Myers Squibb · NCT07106762 A Multicenter Prospective Randomized Controlled Clinical Trial Comparing Constant (5%) Versus Sequential (5%-2%) Oxygen
NA · The Third Affiliated Hospital of Zhengzhou University · The First Affiliated Hospital with Nanjing Medical Universit · NCT07050537 This is a Study to Learn About How the Combination of the Study Medicines Sigvotatug Vedotin Plus Pembrolizumab Works in
Phase 3 · Henan Cancer Hospital · Pfizer · NCT06758401 Evaluation of Rovadicitinib Compared to the Protocol Selected by Researchers in Third Line and Subsequent Studies of Mod
Phase 3 · Henan Provincial People's Hospital · Chia Tai Tianqing Pharmaceutical Group Co., Ltd. · NCT06682169 Energy CT in Imaging and Diagnosis of Gastric Cancer
Phase N/A · The First Affiliated Hospital of Zhengzhou University · The First Affiliated Hospital of Zhengzhou University · NCT06869694 IDEAL Study: Blinded RCT for the Impact of AI Model for Cerebral Aneurysms Detection on Patients' Diagnosis and Outcomes
NA · First Affiliated Hospital of Zhengzhou University · Jinling Hospital, China · NCT06118840 Exhaled Breath Condensate Biomarkers in CARAS
Phase N/A · Henan University of Traditional Chinese Medicine · NCT06573450 A Study to Assess the Adverse Events and How Intravenously Infused Livmoniplimab in Combination With Budigalimab Moves T
Phase 1 · Henan Cancer Hospital /ID# 262098 · AbbVie · NCT06487559 Yangxinshi Tablet Intervention for Exercise Capacity in Patients With Chronic Coronary Syndrome
Phase 4 · Zhengzhou Seventh People's Hospital · Shandong First Medical University · NCT06171061 STOP-HAE: A Phase 3 Study of ADX-324 in HAE
Phase 3 · ADARx Clinical Site · ADARx Pharmaceuticals, Inc. · NCT06960213 A Study of TQB2102 for Injection in the Treatment of HER2-positive Biliary Tract Cancer
Phase 1/Phase 2 · The First Affiliated Hospital of Zhengzhou University · Chia Tai Tianqing Pharmaceutical Group Nanjing Shunxin Pharm · NCT06431490 Clinical Trial of TQB3002 in Patients With Advanced Cancers
Phase 1 · Henan Cancer Hospital · Chia Tai Tianqing Pharmaceutical Group Co., Ltd. · NCT06662760 Efficacy of Nab-PHP Versus TCbHP in Neoadjuvant Therapy for HER2-positive Early Breast Cancer
Phase 3 · Henan cancer hospital · Henan Cancer Hospital · NCT07057427 Cerebral Large Vessel Occlusion Stroke Multiomics Biosample Cohort
Phase N/A · First Affiliated Hospital of Wannan Medical College · NCT06963489 IN10018 Combination Therapy in Treatment-naïve ES-SCLC
Phase 1/Phase 2 · Henan Provincial People's Hospital · InxMed (Shanghai) Co., Ltd. · NCT06030258 The Impact of Transjugular Intrahepatic Portosystemic Shunt on Recompensation in Patients With Decompensated Liver Cirrh
Phase N/A · The First Affiliated Hospital of Zhengzhou University · Union Hospital, Tongji Medical College, Huazhong University · NCT07172035 NOACs Use in AF or VTE (SUNSHINE Registry)
Phase N/A · Henan Provincial People's Hospital · Henan Provincial People's Hospital · NCT05378308 The Chinese Familial Alzheimer's Network
Phase N/A · Henan Provincial People's Hospital · Capital Medical University · NCT03657732 Mobile Applet for Weight Management in Obese Heart Failure Patients
NA · Henan Provincial Chest Hospital · Heart Health Research Center · NCT06455878 Respiratory Disease Cohort Studies of Chinese Medicine for Pulmonary Nodule
Phase N/A · The Third Affiliated Hospital of Henan University of Traditi · Third Affiliated Hospital of Henan University of Traditional · NCT06673121 Comparing the Efficacy of Nab-PH+Pyrrolitinib and TCbHP in the Neoadjuvant Treatment of HER2 Positive BC
Phase 2 · Henan cancer hospital · Henan Cancer Hospital · NCT05918328 Evaluating the Impact of Maridebart Cafraglutide on Cardiovascular Outcomes in Participants With Atherosclerotic Cardiov
Phase 3 · The First Affiliated Hospital of Zhengzhou University · Amgen · NCT07037433 Comparing ICI Followed By CCRT And CCRT Followed By Immunotherapy In Unresectable LA-ESCC
Phase 2 · Henan Cancer Hospital · Tianjin Medical University Cancer Institute and Hospital · NCT07733830

Look up another city

Look up another condition